Immunoblotting of lysates of ibrutinib-treated GBM cells revealed a significant increase of processed LC3A/B-II and Atg7 proteins in a dose- and time-dependent manner; these proteins are critical components in regulating the formation of autophagosomes [21] (Fig. 3c and d). The gene discussed is ATG7; the disease is glioblastoma.